INTELLECTUAL PROPERTY SECURITY AGREEMENT

EX-10.8 9 s103470_ex10-8.htm EXHIBIT 10-8

 

Exhibit 10.8

 

INTELLECTUAL PROPERTY SECURITY AGREEMENT

 

This Intellectual Property Security Agreement (“Agreement”) is entered into as of June 13, 2016 by and among (a) INSPIRE M.D LTD, a a company organized under the laws of the State of Israel whose address is 4 Menorat Hamaor St., Tel Aviv, Israel 67448 (“Grantor”), (b) the several banks and other financial institutions or entities from time to time parties to the Loan Agreement (defined below; collectively, the “Lender”), and (c) HERCULES CAPITAL, INC., a Maryland corporation in its capacity as administrative agent for itself and the Lender (in such capacity, the “Agent”).

 

RECITALS

 

A.           Lender has agreed to make certain advances of money and to extend certain financial accommodations to Grantor (the “Loans”) in the amounts and manner set forth in that certain Loan and Security Agreement by and among Agent, Lender, INSPIREMD, INC., a Delaware corporation, and Grantor dated as of even date hereof (as the same may be amended, modified or supplemented from time to time, the “Loan Agreement”; capitalized terms used herein are used as defined in the Loan Agreement). Lender is willing to make the Loans to Grantor, but only upon the condition, among others, that Grantor shall grant to Agent a security interest in its Copyrights, Trademarks, Patents, and Mask Works (as each term is described below) to secure the obligations of Grantor to Agent and Lender.

 

B.           Pursuant to the terms of the Loan Agreement, Grantor has granted to Agent a security interest in all of Grantor's right, title and interest, whether presently existing or hereafter acquired, in, to and under all of the Collateral.

 

NOW, THEREFORE, for good and valuable consideration, receipt of which is hereby acknowledged, and intending to be legally bound, as collateral security for the prompt and complete payment when due of its obligations to Agent and Lender, Grantor hereby represents, warrants, covenants and agrees as follows:

 

AGREEMENT

 

1.           Grant of Security Interest. To secure its obligations to Agent and Lender, Grantor grants and pledges to Agent a security interest in all of Grantor’s right, title and interest in, to and under its intellectual property (all of which shall collectively be called the “Intellectual Property Collateral”), including, without limitation, the following:

 

(a)          Any and all copyright rights, copyright applications, copyright registrations and like protections in each work of authorship and derivative work thereof, whether published or unpublished and whether or not the same also constitutes a trade secret, now or hereafter existing, created, acquired or held, including without limitation those set forth on Exhibit A attached hereto (collectively, the “Copyrights”);

 

 

 

 

(b)          Any and all trade secrets, and any and all intellectual property rights in computer software and computer software products now or hereafter existing, created, acquired or held;

 

(c)          Any and all design rights that may be available to Grantor now or hereafter existing, created, acquired or held;

 

(d)          All patents, patent applications and like protections including, without limitation, improvements, divisions, continuations, renewals, reissues, extensions and continuations-in-part of the same, including without limitation the patents and patent applications set forth on Exhibit B attached hereto (collectively, the “Patents”);

 

(e)          Any trademark and servicemark rights, whether registered or not, applications to register and registrations of the same and like protections, and the entire goodwill of the business of Grantor connected with and symbolized by such trademarks, including without limitation those set forth on Exhibit C attached hereto (collectively, the “Trademarks”);

 

(f)          All mask works or similar rights available for the protection of semiconductor chips, now owned or hereafter acquired, including, without limitation those set forth on Exhibit D attached hereto (collectively, the “Mask Works”);

 

(g)          Any and all claims for damages by way of past, present and future infringements of any of the rights included above, with the right, but not the obligation, to sue for and collect such damages for said use or infringement of the intellectual property rights identified above;

 

(h)          All licenses or other rights to use any of the Copyrights, Patents, Trademarks, or Mask Works and all license fees and royalties arising from such use to the extent permitted by such license or rights;

 

(i)          All amendments, extensions, renewals and extensions of any of the Copyrights, Trademarks, Patents, or Mask Works; and

 

(j)          All proceeds and products of the foregoing, including without limitation all payments under insurance or any indemnity or warranty payable in respect of any of the foregoing.

 

2.           Recordation. Grantor authorizes the Commissioner for Patents, the Commissioner for Trademarks and the Register of Copyrights and any other government officials to record and register this Agreement upon request by Agent.

 

3.           Loan Documents. This Agreement has been entered into pursuant to and in conjunction with the Loan Agreement, which is hereby incorporated by reference. The provisions of the Loan Agreement shall supersede and control over any conflicting or inconsistent provision herein. The rights and remedies of Agent with respect to the Intellectual Property Collateral are as provided by the Loan Agreement and related documents, and nothing in this Agreement shall be deemed to limit such rights and remedies.

 

 

 

 

4.           Execution in Counterparts. This Agreement may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page to this Agreement by facsimile or in electronic (i.e., "pdf" or "tif" format) shall be effective as delivery of a manually executed counterpart of this Agreement.

 

5.           Successors and Assigns. This Agreement will be binding on and shall inure to the benefit of the parties hereto and their respective successors and assigns.

 

6.           Governing Law. This Agreement and any claim, controversy, dispute or cause of action (whether in contract or tort or otherwise) based upon, arising out of or relating to this Agreement and the transactions contemplated hereby and thereby shall be governed by, and construed in accordance with, the laws of the United States and the State of California, without giving effect to any choice or conflict of law provision or rule (whether of the State of California or any other jurisdiction).

 

[Signature page follows.]

 

 

 

 

IN WITNESS WHEREOF, the parties have caused this Intellectual Property Security Agreement to be duly executed by its officers thereunto duly authorized as of the first date written above.

 

  GRANTOR:
   
  INSPIRE M.D LTD
   
  By: /s/ Craig Shore
     
  Name: Craig Shore
     
  Title: CFO
   
  AGENT:
   
  HERCULES CAPITAL, INC.
   
  By: /s/ Ben Bang
     
  Name: Ben Bang
     
  Title: Associate General Counsel
   
  LENDER:
   
  HERCULES CAPITAL, INC.
   
  By: /s/ Ben Bang
     
  Name: Ben Bang
     
  Title: Associate General Counsel

 

 

 

 

EXHIBIT A

 

Copyrights

 

Description   Registration/
Application
Number
  Registration/
Application
Date
         
None   N/A   N/A

 

 

 

 

EXHIBIT B

 

Patents

 

Description   Registration/
Application
Number (Country)
  Registration/
Application
Date
         
Optimized Stent Jacket   198,665 (IL)   Nov. 21, 2007; issued May 28, 2014
         
Optimized Stent Jacket   ZL200780043259.2 (CN)   Nov. 21, 2007; issued Jan. 2, 2013
         
Optimized Drug-Eluting Stent Assembly   9,132,003 (US); 14/314,777   June 24, 2014; issued Jan. 2, 2013
         
Optimized Stent Jacket   ZL201210454357.8 (CN)   Nov. 13, 2013; issued Dec. 9, 2015
         
Bifurcated Stent Assemblies   198,188 (IL)   Oct. 18, 2007; issued May 1, 2014
         
In Vivo Filter Assembly   8,043,323 (US); 11/582,354   Oct. 18, 2006; issued Oct. 25, 2011
         
Bifurcated Stent Assemblies   8,961,586 (US); 11/797,168   May 1, 2007; issued Feb. 24, 2015
         
In Vivo Filter Assembly   9,132,261 (US); 13/237,977   Sept. 21, 2011; issued Sept. 15, 2015
         
Bifurcated Stent Assemblies   ZL200780046676.2 (CN)   Issued Sept. 26, 2012
         
Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use   2,609,687 (CA)   May 24, 2006; issued April 22, 2014
         
Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use   2,843,097 (CA)   Feb. 20, 2014; issued Oct. 27, 2015

 

 

 

 

Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use   2007/10751 (ZA)   Issued Oct. 27, 2010
         
Filter Assemblies   198189 (IL)   Oct. 18, 2007; issued Mar. 27, 2014
         
Filter Assemblies   2,666,712 (CA)   Oct. 18, 2007; issued Mar. 31, 2015
         
Filter Assemblies   ZL200780046659.9 (CN)   Oct. 18, 2007; issued Mar. 31, 2015
         
Filter Assemblies   201210119132.7 (CN)   Oct. 18, 2007
         
Knitted Stent Jackets   198190 (IL)   Oct. 18, 2007; issued Feb. 1, 2014
         
Knitted Stent Jackets   ZL200780046697.4 (CN)   Issued Oct. 10, 2012; expires Oct. 17, 2027
         
Knitted Stent Jackets   2,666,728 (CA)   Oct. 18, 2007; issued June 23, 2015
         
Knitted Stent Jackets   ZL201210320950.3 (CN)   Oct. 18, 2007; issued Dec. 2, 2015
         
Stent with Sheath and Metal Wire   14/315,001 (US); 2014/0309723   June 25, 2014
         
Stent with Sheath and Metal Wire and Methods   14/705,871 (US); 2015/0230953   May 6, 2015
         
Optimized Stent Jacket   12/791,008 (US); 2010/0241214   June 1, 2010
         
Intravascular Aneurysm Treatment Device And Methods   14/935,339 (US); 2016/0058589   Nov. 6, 2015
         
Optimized Stent Jacket   07827415.6 (EP); EP2088962 A4   Nov. 21, 2007
         
Optimized Stent Jacket   230922 (IL)   Feb. 11, 2014
         
Optimized Stent Jacket   2,670,724 (CA)   Nov. 21, 2007

 

2

 

 

Optimized Stent Jacket   4008/DELNP/2009 (IN)   Nov. 21, 2007
         
Optimized Drug-Eluting Stent Assembly   14/851,882 (US); 2015/0374519   Sept. 11, 2015
         
Bifurcated Stent Assemblies   3113/DELNP/2009 (IN)   Oct. 18, 2007
         
Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use   EP 06745069.2 (EP); EP1885281 A2   May 24, 2006
         
Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use   11/920,972 (US); 2009/0138070   Nov. 23, 2007
         
Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use   187516 (IL)   Nov. 20, 2007
         
Carotid Stent Assembly and Methods for Treatment Via Body Lumens   14/500,759 (US); 2015/0032197   Sept. 29, 2014
         
Filter Assemblies   EP 2007 827228.3 (EP)   Oct. 18, 2007
         
Filter Assemblies   12/445,972 (US); 2010/0204772   Apr. 17, 2009
         
Filter Assemblies   2,881,557 (CA)   Feb. 6, 2015
         
Filter Assemblies   3114/DELNP/2009 (IN)   Oct. 18, 2007
         
Knitted Stent Jackets   EP 07827229.1 (EP); EP ###-###-#### A2   Oct. 18, 2005
         
Knitted Stent Jackets   12/445,980 (US); 2010/0324651   Apr. 17, 2009
         
Knitted Stent Jackets   3171/DELNP/2009 (IN)   Oct. 18, 2007
         
Knitted Stent Jackets   2,887,189 (CA)   Apr. 2, 2015
         
Stent Thermoforming Apparatus and Methods   14/505,310 (US); 2016/0096308   Oct. 2, 2014
         
Stent Thermoforming Apparatus and Methods   PCT/IB2015/057367   Sept. 24, 2015
         
Stent-Mesh Assembly And Methods   14/592,714 (US); 2015/0119971   Jan. 8, 2015
         
Stent with Sheath and Metal Wire Retainer   13/994,739 (US); 2013/0274858   Dec. 18, 2011
         
Deformable Tip For Stent Delivery And Methods Of Use   62/290,031 (US)   Feb. 2, 2016

 

3

 

 

EXHIBIT C

 

Trademarks

 

Description   Registration/
Application
Number (Country)
  Registration/
Application
Date
         
CARENET   013399977 (EU)   Mar. 17, 2015
         
CGUARD   013370978 (EU)   Mar. 26, 2015
         
INSPIREMD     008642118 (EU)   Apr. 26, 2010
         
MGUARD     008642175 (EU)   Apr. 26, 2010
         
MGUARD PRIME   013366141 (EU)   Mar. 12, 2015
         
MICRONET (Class 10) (Supplemental Registration)   4,721,716 (US); 85/659,900   Apr. 14, 2015
         
MNP MicroNet Protection Logo   011737699 (EU)   Sept. 9, 2013
         
CARENET   86/261,697 (US)   Apr. 24, 2014
         
CGuard   86/364,984 (US)   Aug. 13, 2014
         
MGUARD PRIME   86/417,711 (US)   Oct. 8, 2014
         
InspireMD   86/702,932 (US)   July 23, 2015
         
SmartFit   86/702,941 (US)   July 23, 2015
         
PVGuard     86/702,984 (US)   July 23, 2015
         
NGuard     86/702,957 (US)   July 23, 2015
         
AGuard   86/702,971 (US)   July 23, 2015

 

4

 

 

EXHIBIT D

 

Mask Works

 

Description   Registration/
Application
Number
  Registration/
Application
Date
         
None   N/A   N/A